This study aims to find out how well and safe a new medicine, called SP-624, works for adults with Major Depressive Disorder (MDD). MDD is a condition that makes people feel very sad and lose interest in things they used to enjoy. The study compares SP-624 to a placebo, which is a pill with no medicine in it, to see if it truly helps.
To join the study, you should be between 18 and 65 years old, have moderate to severe MDD, and be in good health. You cannot join if you're pregnant or have certain medical conditions like heart problems or high blood pressure. Also, if you have any other serious mental health issues, you may not be eligible.
- The study is a Phase 2B trial, which means it is testing for both safety and effectiveness.
- Participants need to be in good physical health and not have other mental health issues.
- There is no mention of compensation or the exact number of visits required, so inquire about these details if interested.
How understandable was the trial content above?
Hard to understand
Easy to understand